A5078209507- Health Systems, Economic Evaluations, Quality of Life
- Sepsis Diagnosis and Treatment
- Primary Care and Health Outcomes
- Intensive Care Unit Cognitive Disorders
- Heart Failure Treatment and Management
- Influenza Virus Research Studies
- Finance, Taxation, and Governance
- Economic and Financial Impacts of Cancer
- BRCA gene mutations in cancer
- Ethics in Clinical Research
- Healthcare cost, quality, practices
- Biotechnology and Related Fields
- SARS-CoV-2 and COVID-19 Research
- Stoma care and complications
- Iterative Methods for Nonlinear Equations
- HIV-related health complications and treatments
- Emergency and Acute Care Studies
- Aging, Health, and Disability
- Pneumonia and Respiratory Infections
- Frailty in Older Adults
- Healthcare Systems and Technology
- Tuberculosis Research and Epidemiology
- Respiratory viral infections research
- Clinical practice guidelines implementation
- Fractional Differential Equations Solutions
Hospital Reina Sofía de Murcia
2017-2024
Instituto Murciano de Investigación Biosanitaria
2024
Universidad de Murcia
2024
Quebec - Clinical Research Organization in Cancer
2022-2024
(1) Background: The COVID-19 pandemic illuminated vulnerabilities in the Canadian health care system and exposed gaps challenges across cancer continuum. Canada is experiencing significant disruptions to cancer-related services, impact these (delays/deferrals/cancellations) have on patients are yet be determined. Given potential adverse ramifications, how can Canada's systems build resilience for future threats? (2) Methods: To answer this question, CCC facilitated a series of four...
The Canadian system for approval of new cancer drugs is complex with multiple steps. Health Canada grants a license drug to be marketed and prescribed. Agency Drugs Technologies in (CADTH) Institut national d'excellence en santé et services sociaux (INESSS) make recommendations by way health technology assessments (HTA). If positive, the latter then lead confidential price negotiations at pan-Canadian pharmaceutical alliance (pCPA), after which individual provinces territories listing...
1) Background: Genomic medicine harbors the real potential to improve health and healthcare jour-ney of patients, care provider experiences, system efficiency – even reducing costs. There is expected be an exponential growth in medically necessary new genome- based tests test approaches coming years. Testing can also create scientific research commercial opportu-nities beyond decision-making. The purpose this generate a better under-standing Canada’s state readiness for...
The COVID-19 pandemic has highlighted the need to modernize healthcare systems reality of 21st century. first world-wide Strategic Committee launch Collaborative Value-Based Healthcare (C-VBHC) anchored on populational Real World Data and structured collaboration, took place in Montreal, via TOWWERS showcase project. meeting covered a broad range topics from perspective each various Real-World actors, 5P+: Patient, Prescriber, Producer, Policymaker, Payer, including Research stakeholders....
The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field integrated care on a continuous basis.IJIC has Impact Factor 5.120 (2020 JCR, received June 2021)The IJIC 20th Anniversary Issue was published 2021.